The European Union Has Announced the Finalized EU GMP Annex 1

The European Union has announced the finalized EU GMP Annex 1 for manufacturing sterile medicinal products. It is creating some reservations for manufacturers who are not certain how these changes may impact their total manufacturing operation and output. In particular, as the August 2023 deadline approaches manufacturers will need to take time to unpack the changes and understand how they will impact their standard operating procedures.

Jennifer Parker, Director of Marketing at Benchmark Products, is advising manufacturers not to wait to consider these new policies. She anticipates the evaluation of SOPs against the guidelines in Annex 1 will require manufacturers to revise and overhaul processes, as well as implement entirely new processes.

Jennifer’s Thoughts:

Although drafts of the new Annex 1 regulations that govern the manufacturers of sterile medicinal products have been circulating for some years now, it still presents a number of challenges when it was actually released in August of this year. Companies will have some barriers when it comes to clients which they will need to meet by the deadline of August next year.

The first one is understanding the complexity of the Annex 1 regulations, being a 50-page document and affecting almost all the areas of production, it will take some time to read, understand, and then evaluate against your own SOPs. And then that’s where I think the biggest challenge is, around evaluating those SOPs against the guidelines. Will you need to rewrite entire operating procedures? Do you need to add new ones where there weren’t any before? And then finally, how are you going to validate your new SOPs? What criteria will you use and the types of products and procedures that you have in place already, will they be sufficient enough to meet the validation criteria?

These are all complex decisions that companies need to make within the deadline. So I really urge manufacturers that are undergoing this process to start early, form a team, and really understand how much work will be involved to get more manufacturing facilities up to compliance.

Follow us on social media for the latest updates in B2B!

Image

Latest

Salesforce
When Building Beats Buying: A Smarter Approach to Salesforce Decisions at CG Infinity
February 1, 2026

Salesforce offers a broad ecosystem of tools and integrations, giving organizations flexibility but also introducing constant decisions about when to buy, build, or customize. The strongest strategies apply discipline to those choices, ensuring specific requirements are met without adding unnecessary cost or complexity. That balance is a hallmark of how Mike Reeves, Vice President…

Read More
business
How Thoughtful Experience Design Leads to Better Business Outcomes
February 1, 2026

Salesforce gives organizations the ability to automate marketing, personalize outreach, and manage leads at scale—but those benefits only materialize when complex capabilities are implemented cohesively. Through its Salesforce Practice, CG Infinity brings together Marketing Cloud capabilities—including Email Studio, Automation Studio, and Journey Builder—alongside dynamic content, Cloud Pages, and third-party lead integrations. By designing these…

Read More
client
One Team, Shared Goals: Inside CG Infinity’s Client Philosophy
January 31, 2026

Successful Salesforce initiatives rely on alignment as much as technology. When partners stay focused on delivery rather than shared priorities, projects risk meeting technical requirements without achieving real business success. The strongest outcomes come from teams that treat client priorities as the foundation for every decision. That mindset defines how Meagan Diegelman, Principal at…

Read More
Salesforce
Salesforce Works Best When Informed Judgment Comes First
January 31, 2026

Salesforce can be a powerful growth platform, but its complexity can put inexperienced organizations at a disadvantage. Without strong in-house expertise, leaders may struggle to assess recommendations, push back on unnecessary scope, or determine whether proposed solutions truly support business outcomes. Over time, this can lead to overbuilt systems, excess cost, and decisions driven…

Read More